Background Circulating melanocytes can be detected in peripheral blood of patients with
malignant melanoma by means of tyrosinase messenger RNA amplification. In this study we …

The aim of this study was to evaluate the correlation between the detection of circulating
melanoma cells and prognostic criteria for malignant melanoma such as clinical stage …

PURPOSE Circulating melanoma cells can be detected in peripheral blood by means of
tyrosinase mRNA amplification by reverse-transcriptase polymerase chain reaction (RT …

Conflicting results were obtained by various research groups using the tyrosinase reverse
transcription polymerase chain reaction (RT-PCR) for detecting melanoma cells circulating …

Background and Design: Polymerase chain reaction (PCR) detection of circulating tumor
cells from malignant melanoma (MM) was recently described, but the prognostic value of this …

PURPOSE Recently, the reverse-transcription polymerase chain reaction (RT-PCR) of
tyrosinase messenger RNA (mRNA) was reported to be a useful tool for the detection of …

summary Background Circulating tumour cells in the peripheral blood may be important for
haematogenous spread of disease. The detection of these cells may therefore be a poor …

A need for factors predictive of prognosis is present in patients who are diagnosed with
malignant melanoma. The detection of circulating melanoma cells by reverse transcriptase …

Background: Circulating tumor cells can now be identified in subjects with metastatic
melanoma by using the reverse-transcriptase polymerase chain reaction (RT-PCR) to detect …

An improved protocol for reverse transcription–polymerase chain reaction (RT–PCR),
amplifying tyrosinase and MelanA/MART‐1 mRNA from peripheral blood, was used to test …